Page last updated: 2024-10-25

cimetidine and Immune System Diseases

cimetidine has been researched along with Immune System Diseases in 2 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Immune System Diseases: Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mariani, L1
Minora, T1
Soulé, JC1
Delchier, JC1
Morin, T1
Bader, JP1

Reviews

2 reviews available for cimetidine and Immune System Diseases

ArticleYear
[Drug surveillance. Monitoring the side-effects of drugs in the post-marketing phase: cimetidine. II].
    La Clinica terapeutica, 1984, Apr-30, Volume: 109, Issue:2

    Topics: Bone Marrow Diseases; Cardiovascular Diseases; Cimetidine; Drug Interactions; Drug Utilization; Eval

1984
[Maintenance cimetidine treatment in duodenal ulcer disease. Second part: Side-effects and indications (author's transl)].
    Gastroenterologie clinique et biologique, 1980, Volume: 4, Issue:11

    Topics: Animals; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Cimetidine; Confusion; Dogs;

1980